01
Target Identification
Define disease biology, target relevance, and the desired therapeutic mechanism.
Target hypothesis
Hybio Scientific Technology Platform
Engineering the future of peptide therapeutics.
An integrated scientific platform connecting peptide discovery, molecular engineering, development, GMP manufacturing, and global commercialization.
Discovery → Development → Global supply
Peptide Drug Discovery
From biological insight to a development-ready candidate.
Hybio combines target understanding, peptide data, molecular design, and experimental iteration to focus each program on the strongest therapeutic path.
02
Molecular Design
Generate differentiated peptide sequences using data-led design and structure insight.
Designed sequence set
03
Sequence Optimization
Balance potency, selectivity, stability, and manufacturability through iterative testing.
Optimized leads
04
Candidate Selection
Integrate analytical, in-vitro, in-vivo, and process evidence to nominate a candidate.
Development candidate
Connected discovery loop
Computational direction and wet-lab evidence continuously inform one another, improving specificity, stability, and developability before scale-up begins.
Development Pipeline
One scientific thread, maintained from discovery to market.
Scientific knowledge, analytical methods, quality strategy, and process understanding move together across the full peptide development pathway.
01
Discovery
Target insight, sequence design, screening, and early developability assessment.
Output
Candidate
02
Development
API process, formulation, analytical methods, and control strategy are established.
Output
IND-ready package
03
Clinical Evaluation
Clinical supply, stability, quality studies, and regulatory responses advance in parallel.
Output
Clinical evidence
04
Manufacturing
Validated GMP processes scale from development batches to reliable commercial output.
Output
Validated supply
05
Commercialization
Registration, lifecycle management, and global supply connect therapies with patients.
Output
Market access
GMP Manufacturing
Industrial precision without losing scientific control.
Integrated API and formulation facilities translate laboratory knowledge into traceable, scalable, and globally compliant supply.
Scientific control
From analytical precision to repeatable supply.
mg–10T
Integrated Platform
API development through commercial-scale production
6+
Global Compliance
Major regulatory and GMP frameworks supported
50M
Commercial Supply
Annual vial production capacity
01
GMP Manufacturing
Automated synthesis, purification, lyophilization, and multi-dosage formulation infrastructure.
02
Quality Control
Integrated analytical platforms and digital quality systems support end-to-end traceability.
03
Scale-up Production
Process knowledge transfers from laboratory and pilot work into robust commercial operations.
04
Global Supply
Regulatory, registration, and supply teams support clinical and commercial programs worldwide.
Technology Advantages
A platform designed to preserve momentum and knowledge.
Three connected advantages reduce handoffs, strengthen scientific decisions, and protect quality as programs advance.
01
Integrated Platform
Discovery, API, formulation, quality, regulatory, and manufacturing capabilities operate as one connected system.
One program language
02
Scientific Expertise
More than two decades of peptide process data and specialized teams inform faster, evidence-led decisions.
Deep peptide knowledge
03
Global Quality System
International GMP experience and digital quality infrastructure support consistent execution across markets.
Quality by design
Partner With Hybio
Turn a scientific possibility into a therapeutic platform.
Connect with Hybio's scientific team to discuss peptide discovery, development strategy, analytical needs, or scalable manufacturing.
Contact Scientific Team